About Eric Sullivan
Form D filings for Convergent Therapeutics in 2024 list Eric Sullivan as executive officer.
Eric Sullivan first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Eric Sullivan in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Eric Sullivan works with at each company, as listed on that company's latest Form D.
Convergent Therapeutics, Inc. · Form D, Aug 13, 2024
JS
Jake Simson
Director
Tal Zaks
Director
JT
Jim Trenkle
Director
PK
Philip Kantoff
CEO and director
AB
Alexander Brown
Executive officer
NB
Neil Bander
Executive officer and director